Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Right Heart Catheterization During Exercise in Patients with COPD-An Overview of Clinical Results and Methodological Aspects.

Ewert R, Heine A, Bollmann T, Müller-Heinrich A, Gläser S, Opitz CF.

COPD. 2018 Dec;15(6):588-599. doi: 10.1080/15412555.2018.1545832. Review.

PMID:
30894079
2.

Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018.

Rosenkranz S, Lang IM, Blindt R, Bonderman D, Bruch L, Diller GP, Felgendreher R, Gerges C, Hohenforst-Schmidt W, Holt S, Jung C, Kindermann I, Kramer T, Kübler WM, Mitrovic V, Riedel A, Rieth A, Schmeisser A, Wachter R, Weil J, Opitz CF.

Int J Cardiol. 2018 Dec 1;272S:53-62. doi: 10.1016/j.ijcard.2018.08.080. Epub 2018 Aug 27. Review.

PMID:
30527996
3.

Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients.

Delcroix M, Staehler G, Gall H, Grünig E, Held M, Halank M, Klose H, Vonk-Noordegraaf A, Rosenkranz S, Pepke-Zaba J, Opitz CF, Gibbs JSR, Lange TJ, Tsangaris I, Huscher D, Pittrow D, Olsson KM, Hoeper MM.

Eur Respir J. 2018 Nov 8;52(5). pii: 1800248. doi: 10.1183/13993003.00248-2018. Print 2018 Nov.

PMID:
30337446
4.

Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertension.

Richter MJ, Harutyunova S, Bollmann T, Classen S, Gall H, Gerhardt Md F, Grimminger F, Grimminger J, Grünig E, Guth S, Halank M, Heine A, Hoeper MM, Klose H, Lange TJ, Meyer K, Neurohr C, Nickolaus K, Olsson KM, Opitz CF, Rosenkranz S, Seyfarth HJ, Warnke C, Wiedenroth C, Ghofrani HA, Ewert R.

J Heart Lung Transplant. 2018 Oct;37(10):1235-1244. doi: 10.1016/j.healun.2018.06.006. Epub 2018 Jun 21.

PMID:
30293617
5.

Intravenous treprostinil infusion via a fully implantable pump for pulmonary arterial hypertension.

Ewert R, Richter MJ, Steringer-Mascherbauer R, Grünig E, Lange TJ, Opitz CF, Warnke C, Ghofrani HA.

Clin Res Cardiol. 2017 Oct;106(10):776-783. doi: 10.1007/s00392-017-1114-1. Epub 2017 Apr 20.

PMID:
28429083
6.

Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.

Opitz CF, Hoeper MM, Gibbs JS, Kaemmerer H, Pepke-Zaba J, Coghlan JG, Scelsi L, D'Alto M, Olsson KM, Ulrich S, Scholtz W, Schulz U, Grünig E, Vizza CD, Staehler G, Bruch L, Huscher D, Pittrow D, Rosenkranz S.

J Am Coll Cardiol. 2016 Jul 26;68(4):368-78. doi: 10.1016/j.jacc.2016.05.047.

7.

[Dyspnoea in Patients with Pulmonary Hypertension (PH) - a Survey in Spezialized German PH Centres].

Ewert R, Wilkens H, Skowasch D, Reppel M, Bollmann T, Halank M, Held M, Klose H, Gall H, Lange TJ, Opitz CF, Seyfarth HJ, Winkler J.

Pneumologie. 2015 Jun;69(6):361-5. doi: 10.1055/s-0034-1391893. Epub 2015 Apr 21. German.

8.

Response to letters regarding article, "Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)".

Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange TJ, Behr J, Klose H, Claussen M, Ewert R, Opitz CF, Vizza CD, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper MM.

Circulation. 2014 Sep 16;130(12):e110-2. doi: 10.1161/CIRCULATIONAHA.114.010921. No abstract available.

PMID:
25223780
9.

Economic evaluation of exercise training in patients with pulmonary hypertension.

Ehlken N, Verduyn C, Tiede H, Staehler G, Karger G, Nechwatal R, Opitz CF, Klose H, Wilkens H, Rosenkranz S, Halank M, Grünig E.

Lung. 2014 Jun;192(3):359-66. doi: 10.1007/s00408-014-9558-9. Epub 2014 Mar 8.

PMID:
24609926
10.

Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).

Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange TJ, Behr J, Klose H, Claussen M, Ewert R, Opitz CF, Vizza CD, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper MM.

Circulation. 2014 Jan 7;129(1):57-65. doi: 10.1161/CIRCULATIONAHA.113.004526. Epub 2013 Sep 30.

PMID:
24081973
11.

[Early diagnosis and therapy in pulmonary hypertension--aspects of a vision].

Ewert R, Olschewski H, Ghofrani HA, Opitz CF.

Pneumologie. 2013 Jul;67(7):376-87. doi: 10.1055/s-0033-1344316. Epub 2013 Jun 24. Review. German.

12.

Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis.

Avouac J, Huscher D, Furst DE, Opitz CF, Distler O, Allanore Y; EPOSS group.

Ann Rheum Dis. 2014 Jan;73(1):191-7. doi: 10.1136/annrheumdis-2012-202567. Epub 2013 Jan 24.

PMID:
23349131
13.

[The Study of Health in Pomerania (SHIP) reference values for cardiopulmonary exercise testing].

Gläser S, Ittermann T, Schäper C, Obst A, Dörr M, Spielhagen T, Felix SB, Völzke H, Bollmann T, Opitz CF, Warnke C, Koch B, Ewert R.

Pneumologie. 2013 Jan;67(1):58-63. doi: 10.1055/s-0032-1325951. Epub 2012 Dec 17. German.

14.

Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry.

Hoeper MM, Huscher D, Ghofrani HA, Delcroix M, Distler O, Schweiger C, Grunig E, Staehler G, Rosenkranz S, Halank M, Held M, Grohé C, Lange TJ, Behr J, Klose H, Wilkens H, Filusch A, Germann M, Ewert R, Seyfarth HJ, Olsson KM, Opitz CF, Gaine SP, Vizza CD, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Pittrow D.

Int J Cardiol. 2013 Sep 30;168(2):871-80. doi: 10.1016/j.ijcard.2012.10.026. Epub 2012 Nov 17.

PMID:
23164592
15.

Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension.

Wensel R, Francis DP, Meyer FJ, Opitz CF, Bruch L, Halank M, Winkler J, Seyfarth HJ, Gläser S, Blumberg F, Obst A, Dandel M, Hetzer R, Ewert R.

Int J Cardiol. 2013 Aug 20;167(4):1193-8. doi: 10.1016/j.ijcard.2012.03.135. Epub 2012 Apr 10.

PMID:
22494868
16.

Pulmonary hypertension: Hemodynamic evaluation. Updated Recommendations of the Cologne Consensus Conference 2011.

Opitz CF, Blindt R, Blumberg F, Borst MM, Bruch L, Leuchte HH, Lichtblau M, Nagel C, Peters K, Rosenkranz S, Schranz D, Skowasch D, Tiede H, Weil J, Ewert R.

Int J Cardiol. 2011 Dec;154 Suppl 1:S13-9. doi: 10.1016/S0167-5273(11)70489-2.

PMID:
22221969
17.

[Right heart catheterization in pulmonary hypertension].

Rosenkranz S, Behr J, Ewert R, Ghofrani HA, Grünig E, Halank M, Hoeper MM, Leuchte HH, Olschewski H, Schmeisser A, Speich R, Wilkens H, Opitz CF.

Dtsch Med Wochenschr. 2011 Dec;136(50):2601-16; quiz 2617-20. doi: 10.1055/s-0031-1292858. Epub 2011 Dec 7. Review. German. No abstract available.

PMID:
22160954
18.

Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).

Kowal-Bielecka O, Avouac J, Pittrow D, Huscher D, Behrens F, Denton CP, Foeldvari I, Humbert M, Matucci-Cerinic M, Nash P, Opitz CF, Rubin LJ, Seibold JR, Strand V, Furst DE, Distler O; Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis.

J Rheumatol. 2011 Nov;38(11):2419-27. doi: 10.3899/jrheum.110344. Epub 2011 Oct 1. Review.

PMID:
21965635
19.

Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed.

Denton CP, Avouac J, Behrens F, Furst DE, Foeldvari I, Humbert M, Huscher D, Kowal-Bielecka O, Matucci-Cerinic M, Nash P, Opitz CF, Pittrow D, Rubin LJ, Seibold JR, Distler O.

Arthritis Res Ther. 2011 Jun 20;13(3):114. doi: 10.1186/ar3346.

20.

Peripheral endothelial dysfunction is associated with gas exchange inefficiency in smokers.

Gläser S, Obst A, Opitz CF, Dörr M, Felix SB, Empen K, Völzke H, Ewert R, Schäper C, Koch B.

Respir Res. 2011 Apr 25;12:53. doi: 10.1186/1465-9921-12-53.

21.

Prognosis in pulmonary arterial hypertension.

Wensel R, Gläser S, Opitz CF, Ewert R.

Eur Respir J. 2011 Apr;37(4):971-2; author reply 972-3. doi: 10.1183/09031936.00171010. No abstract available.

22.

Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension.

Grünig E, Ehlken N, Ghofrani A, Staehler G, Meyer FJ, Juenger J, Opitz CF, Klose H, Wilkens H, Rosenkranz S, Olschewski H, Halank M.

Respiration. 2011;81(5):394-401. doi: 10.1159/000322475. Epub 2011 Feb 9.

23.

[Pulmonary hypertension: hemodynamic evaluation: hemodynamic evaluation – recommendations of the Cologne Consensus Conference 2010].

Opitz CF, Blindt R, Blumberg F, Borst MM, Bruch L, Leuchte H, Nagel C, Peters K, Rosenkranz S, Schranz D, Skowasch D, Lichtblau M, Tiede H, Weil J, Ewert R; German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Paediatric Cardiology (DGPK).

Dtsch Med Wochenschr. 2010 Oct;135 Suppl 3:S78-86. doi: 10.1055/s-0030-1263315. Epub 2010 Sep 22. German.

PMID:
20862624
24.

Resting alveolar gas tensions as a mortality prognosticator in chronic heart failure.

Schäper C, Gläser S, Wolff B, Koch B, Vietzke G, Felix SB, Kleber FX, Opitz CF, Ewert R.

Transplant Proc. 2010 Sep;42(7):2681-6. doi: 10.1016/j.transproceed.2010.05.166.

PMID:
20832569
25.

Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis.

Huscher D, Pittrow D, Distler O, Denton CP, Foeldvari I, Humbert M, Matucci-Cerinic M, Kowal-Bielecka O, Avouac J, Behrens F, Nash P, Opitz CF, Rubin LJ, Seibold JR, Strand V, Furst DE; EPOSS-OMERACT Group.

Clin Exp Rheumatol. 2010 Mar-Apr;28(2 Suppl 58):S47-52. Epub 2010 Jun 10.

PMID:
20576214
26.

Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group.

Avouac J, Kowal-Bielecka O, Pittrow D, Huscher D, Behrens F, Denton CP, Foeldvari I, Humbert M, Matucci-Cerinic M, Nash P, Opitz CF, Rubin LJ, Seibold JR, Distler O, Furst DE; EPOSS Group.

Ann Rheum Dis. 2010 Jul;69(7):1360-3. doi: 10.1136/ard.2009.120303. Epub 2010 May 14. Review.

27.

Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group.

Kowal-Bielecka O, Avouac J, Pittrow D, Huscher D, Behrens F, Denton CP, Foeldvari I, Humbert M, Matucci-Cerinic M, Nash P, Opitz CF, Rubin LJ, Seibold JR, Strand V, Furst DE, Distler O; EPOSS Group.

J Rheumatol. 2010 Jan;37(1):105-15. doi: 10.3899/jrheum.090661. Epub 2009 Dec 1.

28.

Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).

Khanna D, Distler O, Avouac J, Behrens F, Clements PJ, Denton C, Foeldvari I, Giannini E, Huscher D, Kowal-Bielecka O, Lovell D, Matucci-Cerinic M, Mayes M, Merkel PA, Nash P, Opitz CF, Pittrow D, Rubin L, Seibold JR, Steen V, Strand CV, Tugwell PS, Varga J, Zink A, Furst DE; CRISS; EPOSS.

J Rheumatol. 2009 Oct;36(10):2356-61. doi: 10.3899/jrheum.090372.

29.

[International, prospective register for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension (CompERA-XL)].

Pittrow D, Ghofrani HA, Opitz CF, Huscher D, Hoeper MM.

Dtsch Med Wochenschr. 2009 Aug;134 Suppl 5:S173-5. doi: 10.1055/s-0029-1225318. Epub 2009 Aug 28. Review. German.

PMID:
19718609
30.

[Pulmonary hypertension in left heart disease].

Opitz CF, Gläser S, Ewert R.

Dtsch Med Wochenschr. 2009 Aug;134 Suppl 5:S167-9. doi: 10.1055/s-0029-1225316. Epub 2009 Aug 28. Review. German.

PMID:
19718607
31.

Inhalative iloprost - pharmacology and clinical application.

Ewert R, Schäper C, Halank M, Gläser S, Opitz CF.

Expert Opin Pharmacother. 2009 Sep;10(13):2195-207. doi: 10.1517/14656560903164228.

PMID:
19663611
32.

Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer?

Opitz CF, Rubin LJ.

Eur Respir J. 2009 Jun;33(6):1247-9. doi: 10.1183/09031936.00033809. No abstract available.

33.

Bleeding events in pulmonary arterial hypertension.

Opitz CF, Kirch W, Mueller EA, Pittrow D.

Eur J Clin Invest. 2009 Jun;39 Suppl 2:68-73. doi: 10.1111/j.1365-2362.2009.02122.x. Review. Erratum in: Eur J Clin Invest. 2009 Jul;39(7):630.

PMID:
19335748
34.

Beta-blocker and exercise capacity: an always relevant interference?

Gläser S, Schäper C, Völzke H, Opitz CF, Ewert R, Koch B.

Med Sci Sports Exerc. 2009 Apr;41(4):967; author reply 968. doi: 10.1249/MSS.0b013e3181af696. No abstract available. Erratum in: Med Sci Sports Exerc. 2009 Jun;41(7):1532.

PMID:
19300143
35.

Pulmonary interstitial and vascular abnormalities following cardiac transplantation.

Gläser S, Meyer R, Opitz CF, Hetzer R, Ewert R.

Transplant Proc. 2008 Dec;40(10):3585-9. doi: 10.1016/j.transproceed.2008.06.074.

PMID:
19100444
36.

[Combination therapy in patients with pulmonary arterial hypertension].

Ewert R, Opitz CF, Schäper C, Gläser S.

Dtsch Med Wochenschr. 2008 Oct;133 Suppl 6:S187-90. doi: 10.1055/s-0028-1091235. Epub 2008 Sep 23. Review. German.

PMID:
18814093
37.

Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis.

Gläser S, Noga O, Koch B, Opitz CF, Schmidt B, Temmesfeld B, Dörr M, Ewert R, Schäper C.

Respir Med. 2009 Feb;103(2):317-24. doi: 10.1016/j.rmed.2008.08.005. Epub 2008 Sep 18.

38.

Screening for PAH in patients with systemic sclerosis: focus on Doppler echocardiography.

Sánchez-Román J, Opitz CF, Kowal-Bielecka O, García-Hernández FJ, Castillo-Palma MJ, Pittrow D; EPOSS-OMERACT Group.

Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v33-5. doi: 10.1093/rheumatology/ken306. Review.

PMID:
18784138
39.

Reference values for cardiopulmonary exercise testing in healthy volunteers: the SHIP study.

Koch B, Schäper C, Ittermann T, Spielhagen T, Dörr M, Völzke H, Opitz CF, Ewert R, Gläser S.

Eur Respir J. 2009 Feb;33(2):389-97. doi: 10.1183/09031936.00074208. Epub 2008 Sep 3.

40.

Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?

Opitz CF, Ewert R, Kirch W, Pittrow D.

Eur Heart J. 2008 Aug;29(16):1936-48. doi: 10.1093/eurheartj/ehn234. Epub 2008 Jun 17. Review.

41.

Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis.

Distler O, Behrens F, Pittrow D, Huscher D, Denton CP, Foeldvari I, Humbert M, Matucci-Cerinic M, Nash P, Opitz CF, Rubin LJ, Seibold JR, Furst DE; EPOSS-Omeract Group.

Arthritis Rheum. 2008 Jun 15;59(6):867-75. doi: 10.1002/art.23718. Erratum in: Arthritis Rheum. 2008 Aug 15;59(8):1202.

42.

Influence of the incremental step size in work rate on exercise response and gas exchange in patients with pulmonary hypertension.

Gläser S, Lodziewski S, Koch B, Opitz CF, Völzke H, Ewert R.

BMC Pulm Med. 2008 Feb 23;8:3. doi: 10.1186/1471-2466-8-3.

43.
44.

Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.

Ewert R, Opitz CF, Wensel R, Winkler J, Halank M, Felix SB.

Clin Res Cardiol. 2007 Apr;96(4):211-7. Epub 2007 Feb 15.

PMID:
17294349
45.

Dual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension.

Opitz CF, Ewert R.

Eur J Clin Invest. 2006 Sep;36 Suppl 3:1-9. Review.

PMID:
16919004
46.

[Assessment of cardiopulmonary function at rest and during exercise in patients with pulmonary hypertension].

Ewert R, Opitz CF, Wensel R, Halank M, Winkler J, Lodziewski S, Felix SB.

Herz. 2005 Jun;30(4):318-25. Review. German.

PMID:
15965809
47.

Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.

Opitz CF, Wensel R, Winkler J, Halank M, Bruch L, Kleber FX, Höffken G, Anker SD, Negassa A, Felix SB, Hetzer R, Ewert R.

Eur Heart J. 2005 Sep;26(18):1895-902. Epub 2005 May 11.

PMID:
15888496
48.

[Pregnancy in patients with Eisenmenger's syndrome. Experiences from Vilnius 1967-2003].

Dranenkiene A, Opitz CF, Gumbiené L, Doma B, Ewert R, Bühlmeyer K.

Dtsch Med Wochenschr. 2004 Apr 30;129 Suppl 1:S35-9. German.

PMID:
15133741
49.

Assessment of symptoms and exercise capacity in cyanotic patients with congenital heart disease.

Gläser S, Opitz CF, Bauer U, Wensel R, Ewert R, Lange PE, Kleber FX.

Chest. 2004 Feb;125(2):368-76.

PMID:
14769711
50.

Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.

Opitz CF, Wensel R, Bettmann M, Schaffarczyk R, Linscheid M, Hetzer R, Ewert R.

Eur Heart J. 2003 Feb;24(4):356-65.

PMID:
12581683

Supplemental Content

Loading ...
Support Center